My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 622

    1.

    Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin.

    Miles JM, Leiter L, Hollander P, Wadden T, Anderson JW, Doyle M, Foreyt J, Aronne L, Klein S.

    Diabetes Care. 2002 Jul;25(7):1123-8. Erratum in: Diabetes Care. 2002 Sep;25(9):1671.. PMID: 12087008 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial.

    Kelley DE, Bray GA, Pi-Sunyer FX, Klein S, Hill J, Miles J, Hollander P.

    Diabetes Care. 2002 Jun;25(6):1033-41. Erratum in: Diabetes Care. 2003 Mar;26(3):971.. PMID: 12032111 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.

    Hollander PA, Elbein SC, Hirsch IB, Kelley D, McGill J, Taylor T, Weiss SR, Crockett SE, Kaplan RA, Comstock J, Lucas CP, Lodewick PA, Canovatchel W, Chung J, Hauptman J.

    Diabetes Care. 1998 Aug;21(8):1288-94.PMID: 9702435 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A randomized study of orlistat in combination with a weight management programme in obese patients with Type 2 diabetes treated with metformin.

    Berne C; Orlistat Swedish Type 2 diabetes Study Group.

    Diabet Med. 2005 May;22(5):612-8.PMID: 15842517 [PubMed - indexed for MEDLINE]Related articles

    5.

    Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients.

    Halpern A, Mancini MC, Suplicy H, Zanella MT, Repetto G, Gross J, Jadzinsky M, Barranco J, Aschner P, Ramirez L, Matos AG.

    Diabetes Obes Metab. 2003 May;5(3):180-8.PMID: 12681025 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Pharmacological therapy of obesity]

    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

    G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian. PMID: 18773755 [PubMed - indexed for MEDLINE]Related articles

    7.

    Orlistat in the treatment of overweight or obese Chinese patients with newly diagnosed Type 2 diabetes.

    Shi YF, Pan CY, Hill J, Gao Y.

    Diabet Med. 2005 Dec;22(12):1737-43.PMID: 16401321 [PubMed - indexed for MEDLINE]Related articles

    8.

    The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial.

    Hanefeld M, Sachse G.

    Diabetes Obes Metab. 2002 Nov;4(6):415-23.PMID: 12406041 [PubMed - indexed for MEDLINE]Related articles

    9.

    The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.

    Muls E, Kolanowski J, Scheen A, Van Gaal L; ObelHyx Study Group.

    Int J Obes Relat Metab Disord. 2001 Nov;25(11):1713-21.PMID: 11753595 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.

    Robinson AC, Burke J, Robinson S, Johnston DG, Elkeles RS.

    Diabetes Care. 1998 May;21(5):701-5.PMID: 9589227 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor.

    Finer N, James WP, Kopelman PG, Lean ME, Williams G.

    Int J Obes Relat Metab Disord. 2000 Mar;24(3):306-13.PMID: 10757623 [PubMed - indexed for MEDLINE]Related articles

    12.

    Orlistat in hypertensive overweight/obese patients: results of a randomized clinical trial.

    Bloch KV, Salles GF, Muxfeldt ES, Da Rocha Nogueira A.

    J Hypertens. 2003 Nov;21(11):2159-65.PMID: 14597860 [PubMed - indexed for MEDLINE]Related articles

    13.

    Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.

    Roberts VL, Stewart J, Issa M, Lake B, Melis R.

    Clin Ther. 2005 Oct;27(10):1535-47.PMID: 16330290 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes.

    Kelley DE, Kuller LH, McKolanis TM, Harper P, Mancino J, Kalhan S.

    Diabetes Care. 2004 Jan;27(1):33-40.PMID: 14693963 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin.

    McNulty SJ, Ur E, Williams G; Multicenter Sibutramine Study Group.

    Diabetes Care. 2003 Jan;26(1):125-31.PMID: 12502668 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study.

    Lindgärde F.

    J Intern Med. 2000 Sep;248(3):245-54.PMID: 10971792 [PubMed - indexed for MEDLINE]Related articles

    17.

    Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study.

    Lewin A, Lipetz R, Wu J, Schwartz S.

    Clin Ther. 2007 May;29(5):844-55.PMID: 17697903 [PubMed - indexed for MEDLINE]Related articles

    18.

    Acute effect of orlistat on post-prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus.

    Tan KC, Tso AW, Tam SC, Pang RW, Lam KS.

    Diabet Med. 2002 Nov;19(11):944-8.PMID: 12421432 [PubMed - indexed for MEDLINE]Related articles

    19.

    Acarbose improves glycemic control in overweight type 2 diabetic patients insufficiently treated with metformin.

    Phillips P, Karrasch J, Scott R, Wilson D, Moses R.

    Diabetes Care. 2003 Feb;26(2):269-73.PMID: 12547847 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.

    Derosa G, Cicero AF, Murdolo G, Ciccarelli L, Fogari R.

    Diabetes Nutr Metab. 2004 Aug;17(4):222-9.PMID: 15575343 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity